HUYA Appoints Vice President Of Commercial Planning
This article was originally published in Scrip
HUYA Bioscience International has appointed Scott Garrett vice president, commercial planning. Scott brings over 20 years of commercial experience in drugs and devices for oncology and cardiovascular disease and he previously held positions in companies such as Celladon, Mallinckrodt, Gilead, Johnson and Johnson, Boston Scientific and Nycomed Amersham (now GE Healthcare). His previous responsibilities include sales and marketing, commercial planning, product launch, healthcare economics, reimbursement, advocacy development, life cycle management and business development for brands such as Ceretec, Taxus, Natrecor, Ranexa and Ofirmev.